Autolus Therapeutics (AUTL)

• Market cap: $365M
• 1 day: 7.03%
• 5 days: 0%
• 1 month: -15.43%
• 3 months: -25.95%
• 6 months: 12.3%
• Year to date: -47.91%
• 1 year: -54.49%
• 5 years: -87.27%
• 10 years: -94.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647